Is a complete NSE/TORNTPHARM research report available?

Question

Accepted Answer

No complete published report is available for nse/TORNTPHARM (NSE/TORNTPHARM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	1.9T
Revenue (ttm)	139.8B
Net income (ttm)	21.6B
EPS (ttm)	₹63.9
P/E (trailing)	86.1x
P/E (forward)	76.4x
Dividend	₹38.0 (0.76%)
Volume	549,152

Metric	Value
Country	India
Country code	IN
Employees	18,258
Employees Change	1,199%
Employees Change Percent	7.03
Enterprise value	INR 2.1T
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.63
Industry PE Fwd	34.26
Isin	INE685A01028
Last refreshed	2026-07-29
Market cap	INR 1.9T
Price	INR 4,898
Price currency	INR
Rev Per Employee	7,656,769.64x
Sector	Healthcare
Sector PE	46.31
Sector PE Fwd	37.67
Sic	2834
Symbol	nse/TORNTPHARM
Website	https://www.torrentpharma.com

Metric	Value
Earnings Yield	1.16%
EV Earnings	96.25x
EV/EBIT	60.54x
EV/EBITDA	45.83x
EV/FCF	88.78x
EV/Sales	14.89x
FCF yield	1.26%
Forward P/E	76.39x
P/B ratio	10.6x
P/E ratio	86.14x
P/S ratio	13.33x
PE Ratio10 Y	46.04x
PE Ratio3 Y	56.6x
PE Ratio5 Y	54.86x

Metric	Value
EBIT Margin	24.6%
EBITDA Margin	32.17%
FCF margin	16.78%
Gross margin	75.76%
Gross Profit	INR 105.9B
Gross Profit Growth	21.18%
Gross Profit Growth Q	42.79%
Gross Profit Growth3 Y	15.44%
Gross Profit Growth5 Y	12.57%
Net Income	INR 21.6B
Net Income Growth	13.19%
Net Income Growth Q	-21.85%
Net Income Growth Years	4%
Net Income Growth3 Y	20.22%
Net Income Growth5 Y	11.56%
Pretax Margin	20.55%
Profit Margin	15.48%
Profit Per Employee	INR 1.2M
Profitable Quarters	INR 16
Profitable Years	22
ROA	7.25
Roa5y	9.55
ROCE	9.56
ROE	16.99
Roe5y	20.5
ROIC	12.57
Roic5y	15.33

Metric	Value
Cagr10y	22.89%
Cagr15y	27.2%
Cagr1y	37.15%
Cagr20y	28.69%
Cagr3y	36.27%
Cagr5y	28.21%
Div CAGR10	8.06%
Div CAGR3	19.98%
Div CAGR5	16.77%
EPS Growth	13.19
EPS Growth Q	-21.72
EPS Growth Years	4
EPS Growth3 Y	20.22
EPS Growth5 Y	11.56
FCF Growth	18.86%
FCF Growth3 Y	9.34%
FCF Growth5 Y	7.03%
OCF Growth	16.93%
OCF Growth10 Y	0.98%
OCF Growth3 Y	8.48%
OCF Growth5 Y	8.55%
Revenue Growth	21.39x
Revenue Growth Q	41.83x
Revenue Growth Quarters	25x
Revenue Growth Years	9x
Revenue Growth3 Y	13.27x
Revenue Growth5 Y	11.8x

NSE/TORNTPHARM (NSE/TORNTPHARM)

Coverage state: Market snapshot only — no published research

Generate the first NSE/TORNTPHARM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NSE/TORNTPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/TORNTPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/TORNTPHARM

Frequently asked questions

Metric	Value
Asset Turnover	INR 0.47
Assets	INR 443.1B
Cash	INR 23.6B
Current Assets	INR 93.9B
Current Liabilities	INR 83.4B
Debt	INR 150.3B
Debt EBITDA	INR 3.31
Debt Equity	INR 0.85
Debt FCF	INR 6.41
Equity	INR 175.8B
Interest Coverage	8.94
Liabilities	INR 267.3B
Long Term Assets	INR 349.2B
Long Term Liabilities	INR 183.8B
Net Cash	INR -126.7B
Net Cash By Market Cap	INR -6.8
Net Debt EBITDA	INR 2.82
Net Debt Equity	INR 0.72
Net Debt FCF	INR 5.4
Tangible Book Value	INR -200.6B
Tangible Book Value Per Share	INR -593
WACC	4.8

Metric	Value
Current ratio	1.13
Inventory Turnover	1.19
Net Working Capital	INR 18.8B
Quick ratio	0.72
Working Capital	INR 10.5B
Working Capital Turnover	INR 14.3

Metric	Value
Dividend Growth	18.75%
Dividend Growth Years	2%
Dividend per share	INR 38
Dividend Years	24
Dividend Yield	0.76%
Ex Div Date	2026-05-29
Last Dividend	INR 9
Payout Frequency	Semi-Annual
Payout Ratio	59.58%

Metric	Value
10Y total return	685.21%
1Y total return	37.12%
200-day SMA	4,145.3
3Y total return	153.11%
50-day SMA	4,643.8
50-day SMA vs 200-day SMA	50over200
5Y total return	246.39%
All Time High	5,085.8
All Time High Change	-3.69%
All Time High Date	2026-07-16
All Time Low	9.69
All Time Low Change	50,460.49%
All Time Low Date	2003-04-28
ATR	136.9
Beta	0.14
Ch YTD	27.23
High	5,040
High52	5,085.8
High52 Date	2026-07-16
High52ch	-3.69%
Low	4,866
Low52	3,480.6
Low52 Date	2025-10-14
Low52ch	40.73%
Ma50ch	5.48%
Price vs 200-day SMA	18.16%
RSI	53.83
RSI Monthly	79.37
RSI Weekly	68.05
Sharpe ratio	1.51x
Sortino ratio	2.77
Total Return	0.76%
Tr YTD	28.36
Tr15y	3,591.83%
Tr1m	8.46%
Tr1w	-2.14%
Tr3m	16.31%

Metric	Value
Analyst Count	29
Analyst Ratings	Buy
Operating Income	INR 34.4B
Operating Income Growth	17.55
Operating Income Growth Q	11.08
Operating Income Growth3 Y	17.14
Operating Income Growth5 Y	13.54
Operating margin	24.6
Price target	INR 4,912
Price Target Change	INR 0.29

Metric	Value
Float	145,911,134%
Net Borrowing	118,670,000,000
Shares Insiders	0.25%
Shares Institutions	16.8%
Shares Qo Q	-0.1%

Metric	Value
Average Volume	793,274.55x
Bv Per Share	247.9
CAPEX	INR -6.8B
Ch10y	596.5
Ch15y	2,869.6
Ch1m	8.46
Ch1w	-2.14
Ch1y	35.92
Ch20y	11,415.1
Ch3m	16.08
Ch3y	145.9
Ch5y	226.2
Ch6m	22.54
Change	-2.41%
Change From Open	-2.43
Close	5,019.5
Days Gap	0.01
Depreciation Amortization	10,570,500,000
Dollar Volume	2,689,911,241.6
Earnings Date	2026-07-30
EBIT	INR 34.4B
EBITDA	INR 45B
EPS	INR 63.92
F Score	4
FCF	INR 23.5B
FCF EV Yield	1.13x
Financing CF	101,506,000,000
Fiscal Year End	March
Founded	1,959
Goodwill	39,896,200,000
Graham Number	769.0123
Graham Upside	-84.3
Income Tax	INR 7.3B
Investing CF	-127,124,100,000
Is Primary Listing	0
Last Earnings Date	2026-05-22
Last Report Date	2026-03-31
Last Split Date	2022-07-08
Last Split Type	Forward
Lynch Fair Value	INR 657
Lynch Upside	-86.58
Ma150	4,301.7
Ma150ch	13.87%
Ma20	4,906.7
Ma20ch	-0.17%
Net CF	5,437,200,000
Next Earnings Date	2026-07-30
Open	5,020.1
P FCF Ratio	79.46
P OCF Ratio	61.65
Position In Range	18.56
Ppne	53,660,200,000
Price Date	2026-07-28
Price EBITDA	INR 41.44
Relative Volume	0.69x
Revenue	139,797,300,000x
Tax By Revenue	5.25x
Tax Rate	25.56%
Tr20y	15,416.28%
Tr6m	23.62%
Volume	549,152
Z Score	3.65